A peptide name is useful shorthand, but molecular identity depends on more than the label. The amino-acid sequence, terminal chemistry, covalent modifications, stereochemistry, disulfide pattern, metal association, salt or counterion, and formulation context can all distinguish one material from another. An identity record should publish only fields supported by an authoritative source or product-specific documentation.
Sequence as primary structure
Sequence records the ordered amino-acid residues from the amino terminus to the carboxyl terminus using one-letter or three-letter codes. Order matters: peptides with the same composition but different residue order are different sequences. A deletion, insertion, substitution, or epimer can alter mass, chromatographic behavior, and biological interaction.
Short catalog names can hide ambiguity. A name may refer to a native sequence, an analog, a fragment, or a proprietary abbreviation. Before publishing a sequence, the editorial record should show that the selected source refers to the exact compound rather than a related family member.
Termini and modifications
N-terminal acetylation, C-terminal amidation, cyclization, lipidation, labels, and other modifications change identity. Disulfide connectivity can matter even when the residue sequence is unchanged. Copper-associated peptides such as GHK-Cu add a coordination context. Salt state and counterion may affect formula and molecular weight reported for a record.
These details explain why two database pages can appear to describe the same common name while reporting different formulas. The correct response is not to choose the first search result, but to identify the chemical form actually supported by the source and product documentation.
Identifiers and database records
PubChem CIDs identify standardized compound records; CAS numbers come from a different registry system; sequence-database accessions identify biological records. Synonyms are search aids, not proof that every name maps unambiguously to one structure. PubChem documentation specifically notes that name matching can be inexact and that multiple records may be returned.
Molecular formula and average molecular weight are properties of the defined chemical record. They do not certify a vendor’s batch or describe a mixture. A blend has component identities rather than one universal formula. A formulated solution includes more than the named solute.
How identity is measured
Mass spectrometry can compare observed ions with expected molecular mass. Tandem MS can provide fragment evidence related to sequence. Chromatographic comparison, amino-acid analysis, NMR, optical or spectroscopic methods, and reference standards can add orthogonal evidence. The method should be chosen for the identity question and known ambiguities.
An intact-mass match may not distinguish isomers or every sequence arrangement. A database formula may be correct for a reference record but says nothing about whether the submitted sample matches it. Reference data and experimental evidence should be connected, not conflated.
Building an identity record
A structured record can contain canonical name, synonyms, sequence, terminal or other modifications, formula, molecular weight, CAS number, PubChem CID, classification, and authoritative URLs. Fields should remain blank when the source match is not sufficiently specific. The LiveWire Research Database follows this evidence-first model.
Product pages then link to the record for reference context while maintaining their separate procurement purpose. Batch identity evidence belongs in a connected laboratory report. This three-layer structure prevents a database identifier from being misrepresented as product or batch certification.
Common identity ambiguities
Leucine and isoleucine have the same nominal mass; sequence order can change without changing composition; D- and L-residues require stereochemical distinction; and oxidation can add mass without changing the underlying sequence notation. Amidated and free-acid termini differ. Copper complexes, disulfides, and cyclic forms introduce still other questions.
These examples show why a name, formula, or intact mass can be necessary but insufficient. The identity strategy should anticipate the plausible alternatives created by synthesis, degradation, and naming conventions.
A hierarchy for publishing identifiers
- Start with product-specific supplier documentation and the intended catalog identity.
- Find an authoritative exact reference such as PubChem, UniProt, or primary literature.
- Confirm sequence, termini, modifications, and chemical form agree.
- Publish only matching fields and retain source URLs.
- Label reference properties as reference properties, not batch results.
- Use experimental batch data to support product identity separately.
If sources disagree, preserve the discrepancy and keep the public field blank. Editorial restraint prevents an uncertain value from propagating across schema, product tables, articles, and search indexes.
Add LiveWire as a preferred source
Use Google’s standard Preferred Sources control to make LiveWire Peptides easier to find in supported Google experiences.
References
- Bailly-Chouriberry L, Cormant F, Garcia P, et al.. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. The AAPS Journal. 2023. PMID 36949371 Peer-reviewed primary/methods literature
- Højrup P. Characterization of Synthetic Peptides by Mass Spectrometry. Methods in Molecular Biology. 2015. PMID 26424265; DOI 10.1007/978-1-4939-2999-3_9 Peer-reviewed methods literature
- National Center for Biotechnology Information. PubChem PUG REST Documentation. NIH PubChem. 2026 Authoritative scientific database documentation
- Muth T, Hartkopf F, Vaudel M, Renard BY. Algorithms for De-novo Sequencing of Peptides by Tandem Mass Spectrometry: A Review. Analytica Chimica Acta. 2023. PMID 37268337; DOI 10.1016/j.aca.2023.341330 Peer-reviewed review